PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment.
作者信息
Jones D, Woyach J A, Zhao W, Caruthers S, Tu H, Coleman J, Byrd J C, Johnson A J, Lozanski G
机构信息
Department of Pathology, The Ohio State University and James Cancer Hospital, Columbus, OH, USA.
Division of Hematology, Department of Internal Medicine, The Ohio State University and James Cancer Hospital, Columbus, OH, USA.
出版信息
Leukemia. 2017 Jul;31(7):1645-1647. doi: 10.1038/leu.2017.110. Epub 2017 Apr 3.
PMID:28366935
Abstract
摘要
Zotero 插件